← Back to Clinical Trials
Recruiting NCT07029490

NCT07029490 Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07029490
Status Recruiting
Phase
Sponsor University of Utah
Condition Breast Cancer
Study Type INTERVENTIONAL
Enrollment 2,700 participants
Start Date 2025-11-19
Primary Completion 2028-03

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Chatbot

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 2,700 participants in total. It began in 2025-11-19 with a primary completion date of 2028-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is investigating the feasibility of a digital tool called a chatbot for providing educational information about mammography through a tablet, computer, or phone. This study will recruit participants who recently had a mammogram with the University of Utah. Based on their mammography results, women will be placed into two cohorts using their BI-RADS category. Once mammogram results are available, patients will be randomized 1:1 to either usual care or usual care with chatbot. This study will randomly invite participants from four groups for focus group discussions (FGDs) based on their mammogram results and adherence to screening recommendations

Eligibility Criteria

Inclusion Criteria: * Adult (equal to or above 18 years old) * English or Spanish speaking * Visit a mammography program for routine screening. Exclusion Criteria: * Patients who are currently in treatment for breast cancer * Patients who are not of 18 years of age. * Patients who don't speak English or Spanish * Men * Cognitive limitations that impede informed consent

Contact & Investigator

Central Contact

Anthony Ariotti

✉ anthony.ariotti@hsc.utah.edu

📞 801-213-6542

Frequently Asked Questions

Who can join the NCT07029490 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07029490 currently recruiting?

Yes, NCT07029490 is actively recruiting participants. Contact the research team at anthony.ariotti@hsc.utah.edu for enrollment information.

Where is the NCT07029490 trial being conducted?

This trial is being conducted at Salt Lake City, United States.

Who is sponsoring the NCT07029490 clinical trial?

NCT07029490 is sponsored by University of Utah. The trial plans to enroll 2,700 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology